These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38878592)
1. Pharmacological interventions for antipsychotic-induced weight gain in schizophrenia: A network meta-analysis. Hegde NC; Mishra A; Maiti R; Mishra BR; Mohapatra D; Srinivasan A Gen Hosp Psychiatry; 2024; 90():12-21. PubMed ID: 38878592 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological interventions for prevention of weight gain in people with schizophrenia. Agarwal SM; Stogios N; Ahsan ZA; Lockwood JT; Duncan MJ; Takeuchi H; Cohn T; Taylor VH; Remington G; Faulkner GEJ; Hahn M Cochrane Database Syst Rev; 2022 Oct; 10(10):CD013337. PubMed ID: 36190739 [TBL] [Abstract][Full Text] [Related]
3. [Prevention and treatment of antipsychotic induced weight gain]. Veerman SRT; Cohen D Tijdschr Psychiatr; 2023; 65(4):259-265. PubMed ID: 37323046 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain. Ellinger LK; Ipema HJ; Stachnik JM Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913 [TBL] [Abstract][Full Text] [Related]
5. Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis. Yoshida K; Maciukiewicz M; Zai CC; Gonçalves VF; Brandl EJ; Lieberman JA; Meltzer HY; Tiwari AK; Kennedy JL; Müller DJ Prog Neuropsychopharmacol Biol Psychiatry; 2020 Aug; 102():109952. PubMed ID: 32335267 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis. Mizuno Y; Suzuki T; Nakagawa A; Yoshida K; Mimura M; Fleischhacker WW; Uchida H Schizophr Bull; 2014 Nov; 40(6):1385-403. PubMed ID: 24636967 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological Interventions of Atypical Antipsychotics Induced Weight Gain in the Pediatric Population: A Systemic Review of Current Evidence. Al Jumaili W; Muzwagi A; Shah K; Trivedi C; Durga P; Mansuri Z; Jain S; Al Jumaili Y Child Psychiatry Hum Dev; 2024 Apr; 55(2):479-487. PubMed ID: 36066654 [TBL] [Abstract][Full Text] [Related]
8. Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis. Zhuo C; Xu Y; Liu S; Li J; Zheng Q; Gao X; Li S; Jing R; Song X; Yue W; Zhou C; Upthegrove R Front Pharmacol; 2018; 9():1393. PubMed ID: 30546312 [No Abstract] [Full Text] [Related]
9. Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial. de Boer N; Guloksuz S; van Baal C; Willebrands L; Deenik J; Vinkers CH; Rossum IW; Zinkstok J; Wilting I; Zantvoord JB; Backx F; Swildens WE; Schouw M; Bogers J; Hulshof F; de Knijff R; Duindam P; Veereschild M; Bak M; Frederix G; de Haan L; van Os J; Cahn W; Luykx JJ BMC Psychiatry; 2021 Jan; 21(1):4. PubMed ID: 33402159 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive-compulsive disorder: A network meta-analysis. Maiti R; Mishra A; Srinivasan A; Mishra BR Acta Psychiatr Scand; 2023 Jul; 148(1):19-31. PubMed ID: 37177823 [TBL] [Abstract][Full Text] [Related]
11. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis. De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of pharmacological interventions on metabolic disturbance induced by atypical antipsychotics in adults: A systematic review and network meta-analysis. Wang Y; Wang D; Cheng J; Fang X; Chen Y; Yu L; Ren J; Tian Y; Zhang C J Psychopharmacol; 2021 Sep; 35(9):1111-1119. PubMed ID: 34311625 [TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis. Maayan L; Vakhrusheva J; Correll CU Neuropsychopharmacology; 2010 Jun; 35(7):1520-30. PubMed ID: 20336059 [TBL] [Abstract][Full Text] [Related]
17. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. de Silva VA; Suraweera C; Ratnatunga SS; Dayabandara M; Wanniarachchi N; Hanwella R BMC Psychiatry; 2016 Oct; 16(1):341. PubMed ID: 27716110 [TBL] [Abstract][Full Text] [Related]
18. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481 [TBL] [Abstract][Full Text] [Related]
19. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia. Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945 [TBL] [Abstract][Full Text] [Related]
20. Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review. Martínez-Ortega JM; Funes-Godoy S; Díaz-Atienza F; Gutiérrez-Rojas L; Pérez-Costillas L; Gurpegui M Eur Child Adolesc Psychiatry; 2013 Aug; 22(8):457-79. PubMed ID: 23503976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]